Skip to main content
Corbion N.V. logo

Corbion N.V. — Investor Relations & Filings

Ticker · CRBN ISIN · NL0010583399 LEI · 724500BKS1TSAVLTWG46 AS Manufacturing
Open in API
Filings indexed 667 across all filing types
Latest filing 2012-10-25 Earnings Release
Country NL Netherlands
Listing AS CRBN

About Corbion N.V.

https://www.corbion.com/

Corbion is a global company specializing in sustainable food ingredients and biochemical solutions. Leveraging expertise in fermentation and application development, it produces biobased products from renewable resources. The company's portfolio includes lactic acid and its derivatives, lactides, food preservation solutions, functional ingredient blends, and algae-derived nutritional ingredients. These products are designed to enhance food preservation, safety, and nutrition. Corbion also develops solutions for the biochemical, biomedical, and bioplastics sectors, focusing on sustainable innovation.

Recent filings

Filing Released Lang Actions
CSM Interim Management Statement derde kwartaal 2012
Earnings Release Classification · 1% confidence The document is a 'Persbericht' (Press Release) titled 'CSM Interim Management Statement derde kwartaal 2012'. It provides a detailed breakdown of financial performance, including revenue, EBITA, and divisional analysis for the third quarter and the first nine months of 2012. While it contains substantive financial data and analysis, it is structured as an earnings release/interim management statement rather than a full statutory interim report. According to the provided definitions, this fits the 'Earnings Release' (ER) category as it serves as the initial announcement of quarterly financial results with key highlights. Q3 2012
2012-10-25 Dutch
CSM Interim Management Statement derde kwartaal 2012
Interim / Quarterly Report Classification · 1% confidence The document is a 'Q3 2012 Interim Management Statement' from CSM nv. It contains detailed financial performance data, including sales, EBITA, and year-to-date comparisons, as well as management commentary on business developments and strategic transformation. Because it provides substantive financial data and analysis for a period shorter than a full fiscal year (Q3), it qualifies as an Interim/Quarterly Report (IR) rather than a simple press release or announcement. Q3 2012
2012-10-25 Dutch
BASF and CSM establish 50-50 joint venture company for biobased succinic acid
M&A Activity Classification · 1% confidence The document is a joint press release from BASF and CSM announcing the formation of a 50-50 joint venture named Succinity GmbH to produce bio-based succinic acid. It details the strategic rationale, production plans (including capacity figures for 2013), and quotes from executives. This type of announcement, detailing a significant corporate transaction (formation of a joint venture) and future operational plans, is typically classified as a general corporate announcement or a financing/capital activity update, depending on the specific focus. Since it involves a major strategic partnership and future production capacity, it relates closely to capital structure/financing activities or strategic corporate news. Given the options, 'Capital/Financing Update' (CAP) fits well as it concerns a major structural change and investment plan, although 'Regulatory Filings' (RNS) could be a fallback. However, the content is a direct announcement of a business transaction rather than a regulatory filing notification. It is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K). It is a specific business development announcement. I will classify this as a Capital/Financing Update (CAP) because it announces the creation of a new entity and plans for industrial-scale production/investment, which impacts capital structure and future financing needs.
2012-10-05 English
BASF and CSM establish 50-50 joint venture company for biobased succinic acid
Regulatory Filings Classification · 1% confidence The document is titled "Joint News Release of BASF and CSM" and announces the establishment of a 50-50 joint venture company, Succinity GmbH, for biobased succinic acid production. It details the strategic rationale, operational plans (including facility modifications and capacity), and includes quotes from executives of both parent companies. This content is characteristic of a corporate announcement regarding a significant business transaction or strategic partnership, rather than a mandatory regulatory filing like a 10-K, an earnings release (ER), or a formal capital structure change (CAP). Since it is a joint announcement detailing a new business entity and strategic move, it fits best under the general category of corporate news or a regulatory filing that doesn't fit a more specific category. Given the options, it is a significant corporate announcement. It is not a standard earnings release (ER), a formal report (10-K, IR), or a management discussion (MDA). It is most closely aligned with a general corporate announcement, which often falls under Regulatory Filings (RNS) if no other specific category like M&A (TAR) applies, although this is a JV formation. Since it is a press release announcing a major business development, RNS (Regulatory Filings/General Announcement) is the most appropriate fallback, as it is not a specific report type listed.
2012-10-05 English
Earnings Release 2012
Earnings Release Classification · 1% confidence The document is a press release dated August 8, 2012, detailing the financial performance for the 'second quarter of 2012' and the 'first half-year'. It presents key financial metrics (Sales, EBITA, Net Debt, EPS) and includes commentary from the CEO regarding results and future prospects. This structure—a summary of recent financial results released outside of a formal 10-K or 10-Q filing—is characteristic of an Earnings Release (ER). Although it contains detailed financial commentary similar to a Management Discussion and Analysis (MDA), its primary function as an initial, high-level announcement of period results points strongly to ER. It is not a full Annual Report (10-K) or a comprehensive Interim Report (IR) as it explicitly states the figures 'have not been audited' and focuses on highlights and commentary. Q2 2012
2012-08-09 English
CSM laat EBITA-stijging zien in tweede kwartaal 2012
Earnings Release Classification · 1% confidence The document is a press release dated August 8, 2012, detailing the financial results for the second quarter and first half of 2012. It explicitly mentions key financial metrics like revenue, EBITA, and net debt, and includes commentary from the CEO regarding performance and outlook. This structure—a summary of recent period results released via a press release—is characteristic of an Earnings Release (ER). Although it contains detailed financial tables, its primary function, as indicated by the format and introductory nature, is the initial announcement of results, rather than the comprehensive, formally filed report (like a 10-K or IR). The document is too detailed to be a simple Report Publication Announcement (RPA) which usually just points to the full report. H1 2012
2012-08-08 Dutch

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.